The United States Biologic Therapeutics Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Biologic Therapeutics industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologic Therapeutics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologic Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 146 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
1 Industry Overview
1.1 Definition and Specifications of Biologic Therapeutics
1.2 Classification of Biologic Therapeutics
1.2.1 Protein therapeutics market
1.2.2 Vaccines market
1.2.3 Cell therapy market
1.3 Applications of Biologic Therapeutics
1.4 Industry Chain Structure of Biologic Therapeutics
1.5 Industry Overview of Biologic Therapeutics
1.6 Industry Policy Analysis of Biologic Therapeutics
1.7 Industry News Analysis of Biologic Therapeutics
2 Manufacturing Cost Structure Analysis of Biologic Therapeutics
2.1 Bill of Materials (BOM) of Biologic Therapeutics
2.2 BOM Price Analysis of Biologic Therapeutics
2.3 Labor Cost Analysis of Biologic Therapeutics
2.4 Depreciation Cost Analysis of Biologic Therapeutics
2.5 Manufacturing Cost Structure Analysis of Biologic Therapeutics
2.6 Manufacturing Process Analysis of Biologic Therapeutics
2.7 China Price, Cost and Gross of Biologic Therapeutics 2010-2015
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Biologic Therapeutics Manufacturers in 2014
3.3 R & D Status and Technology Source of United States Biologic Therapeutics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Biologic Therapeutics Key Manufacturers in 2014
4 Production Analysis of Biologic Therapeutics by Regions, Type, and Applications
4.1 United States Production of Biologic Therapeutics by Regions 2010-2015
4.2 United States Production of Biologic Therapeutics by Type 2010-2015
4.3 United States Sales of Biologic Therapeutics by Applications 2010-2015
4.4 Price Analysis of United States Biologic Therapeutics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biologic Therapeutics 2010-2015
5 Consumption Volume and Consumption Value Analysis of Biologic Therapeutics by Regions
5.1 United States Consumption Volume of Biologic Therapeutics by Regions 2010-2015
5.2 United States Consumption Value of Biologic Therapeutics by Regions 2010-2015
5.3 United States Consumption Price Analysis of Biologic Therapeutics by Regions 2010-2015
6 Analysis of Biologic Therapeutics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Biologic Therapeutics 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Biologic Therapeutics 2014-2015
6.3 Sales Overview of Biologic Therapeutics 2010-2015
6.4 Supply, Consumption and Gap of Biologic Therapeutics 2010-2015
6.5 Import, Export and Consumption of Biologic Therapeutics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Biologic Therapeutics 2010-2015
7 Analysis of Biologic Therapeutics Industry Key Manufacturers
7.1 Amgen
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Amgen SWOT Analysis
7.2 Roche
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Roche SWOT Analysis
7.3 Novo Nordisk
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Novo Nordisk SWOT Analysis
7.4 Sanofi
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Sanofi SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Biologic Therapeutics Product Types
8.5 Market Share Analysis of Different Biologic Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Biologic Therapeutics Applications
9 Marketing Trader or Distributor Analysis of Biologic Therapeutics
9.1 Marketing Channels Status of Biologic Therapeutics
9.2 Traders or Distributors of Biologic Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biologic Therapeutics
9.4 United States Import, Export and Trade Analysis of Biologic Therapeutics
10 Development Trend of Biologic Therapeutics Industry 2016-2021
10.1 Capacity and Production Overview of Biologic Therapeutics 2016-2021
10.2 Production Market Share by Product Types of Biologic Therapeutics 2016-2021
10.3 Sales and Sales Revenue Overview of Biologic Therapeutics 2016-2021
10.4 United States Sales of Biologic Therapeutics by Applications 2016-2021
10.5 Import, Export and Consumption of Biologic Therapeutics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Biologic Therapeutics 2016-2021
11 Industry Chain Suppliers of Biologic Therapeutics with Contact Information
11.1 Major Raw Materials Suppliers of Biologic Therapeutics with Contact Information
11.2 Manufacturing Equipment Suppliers of Biologic Therapeutics with Contact Information
11.3 Major Players of Biologic Therapeutics with Contact Information
11.4 Key Consumers of Biologic Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Biologic Therapeutics
12 New Project Investment Feasibility Analysis of Biologic Therapeutics
12.1 New Project SWOT Analysis of Biologic Therapeutics
12.2 New Project Investment Feasibility Analysis of Biologic Therapeutics
13 Conclusion of the United States Biologic Therapeutics Industry 2015 Deep Market Research Report
List of Tables and Figures
Figure Picture of Biologic Therapeutics
Table Product Specifications of Biologic Therapeutics
Table Classification of Biologic Therapeutics
Figure United States Sales Market Share of Biologic Therapeutics by Product Types in 2014
Table Applications of Biologic Therapeutics
Figure United States Sales Market Share of Biologic Therapeutics by Applications in 2014
Figure Industry Chain Structure of Biologic Therapeutics
Table United States Industry Overview of Biologic Therapeutics
Table Industry Policy of Biologic Therapeutics
Table Industry News List of Biologic Therapeutics
Table Bill of Materials (BOM) of Biologic Therapeutics
Table Bill of Materials (BOM) Price of Biologic Therapeutics
Table Labor Cost of Biologic Therapeutics
Table Depreciation Cost of Biologic Therapeutics
Table Manufacturing Cost Structure Analysis of Biologic Therapeutics in 2014
Figure Manufacturing Process Analysis of Biologic Therapeutics
Table United States Price Analysis of Biologic Therapeutics 2010-2015 (USD/Dose)
Table United States Cost Analysis of Biologic Therapeutics 2010-2015 (USD/Dose)
Table United States Gross Analysis of Biologic Therapeutics 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Biologic Therapeutics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Biologic Therapeutics Manufacturers in 2014
Table R & D Status and Technology Source of United States Biologic Therapeutics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Biologic Therapeutics Key Manufacturers in 2014
Table United States Production of Biologic Therapeutics by Regions 2010-2015 (Doses)
Table United States Production Market Share of Biologic Therapeutics by Regions 2010-2015
Figure United States Production Market Share of Biologic Therapeutics by Regions in 2014
Figure United States Production Market Share of Biologic Therapeutics by Regions in 2015
Table United States Production of Biologic Therapeutics by Types in 2010-2015 (Doses)
Table United States Production Market Share of Biologic Therapeutics by Type in 2010-2015
Figure United States Production Market Share of Biologic Therapeutics by Type in 2014
Figure United States Production Market Share of Biologic Therapeutics by Type in 2015
Table United States Sales of Biologic Therapeutics by Applications 2010-2015 (Doses)
Table United States Production Market Share of Biologic Therapeutics by Applications 2010-2015
Figure United States Production Market Share of Biologic Therapeutics by Applications in 2014
Figure United States Production Market Share of Biologic Therapeutics by Applications in 2015
Table Price Comparison of United States Biologic Therapeutics Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biologic Therapeutics 2010-2015
Table United States Consumption Volume of Biologic Therapeutics by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Biologic Therapeutics by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Biologic Therapeutics by Regions in 2014
Figure United States Consumption Volume Market Share of Biologic Therapeutics by Regions in 2015
Table United States Consumption Value of Biologic Therapeutics by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Biologic Therapeutics by Regions 2010-2015
Figure United States Consumption Value Market Share of Biologic Therapeutics by Regions in 2014
Figure United States Consumption Value Market Share of Biologic Therapeutics by Regions in 2015
Table Consumption Price of Biologic Therapeutics by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Biologic Therapeutics 2010-2015 (Doses)
Table United States Capacity Market Share of Major Biologic Therapeutics Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Biologic Therapeutics 2010-2015 (Doses)
Table United States Production Market Share of Major Biologic Therapeutics Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Biologic Therapeutics 2010-2015 (Doses)
Table United States Sales Market Share of Major Biologic Therapeutics Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Biologic Therapeutics 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Biologic Therapeutics Manufacturers 2010-2015
Figure United States Capacity (Doses) , Production (Doses) and Growth Rate of Biologic Therapeutics 2010-2015
Figure United States Capacity Utilization Rate of Biologic Therapeutics 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Biologic Therapeutics 2010-2015
Figure United States Production Market Share of Major Biologic Therapeutics Manufacturers in 2014
Figure United States Production Market Share of Major Biologic Therapeutics Manufacturers in 2015
Figure United States Sales Market Share of Major Biologic Therapeutics Manufacturers in 2014
Figure United States Sales Market Share of Major Biologic Therapeutics Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Biologic Therapeutics 2010-2015
Table United States Supply, Consumption and Gap of Biologic Therapeutics 2010-2015 (Doses)
Table United States Import, Export and Consumption of Biologic Therapeutics 2010-2015 (Doses)
Table Price of United States Biologic Therapeutics Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Biologic Therapeutics Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Biologic Therapeutics 2010-2015 (M USD)
Table United States Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Revenue (M USD) and Gross Margin of Biologic Therapeutics 2010-2015
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biologic Therapeutics Picture and Specifications of Amgen
Table Biologic Therapeutics Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Biologic Therapeutics Capacity (Doses) , Production (Doses) and Growth Rate of Amgen 2010-2015
Figure Biologic Therapeutics Production (Doses) and United States Market Share of Amgen 2010-2015
Table Amgen Biologic Therapeutics SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biologic Therapeutics Picture and Specifications of Roche
Table Biologic Therapeutics Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Biologic Therapeutics Capacity (Doses) , Production (Doses) and Growth Rate of Roche 2010-2015
Figure Biologic Therapeutics Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Biologic Therapeutics SWOT Analysis
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biologic Therapeutics Picture and Specifications of Novo Nordisk
Table Biologic Therapeutics Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Novo Nordisk 2010-2015
Figure Biologic Therapeutics Capacity (Doses) , Production (Doses) and Growth Rate of Novo Nordisk 2010-2015
Figure Biologic Therapeutics Production (Doses) and United States Market Share of Novo Nordisk 2010-2015
Table Novo Nordisk Biologic Therapeutics SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biologic Therapeutics Picture and Specifications of Sanofi
Table Biologic Therapeutics Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Sanofi 2010-2015
Figure Biologic Therapeutics Capacity (Doses) , Production (Doses) and Growth Rate of Sanofi 2010-2015
Figure Biologic Therapeutics Production (Doses) and United States Market Share of Sanofi 2010-2015
Table Sanofi Biologic Therapeutics SWOT Analysis
Table Biologic Therapeutics Price by Regions 2010-2015
Table Biologic Therapeutics Price by Product Types 2010-2015
Table Biologic Therapeutics Price by Companies 2010-2015
Table Biologic Therapeutics Gross Margin by Companies 2010-2015
Table Price Comparison of Biologic Therapeutics by Regions 2010-2015 (USD/Dose)
Table Price of Different Biologic Therapeutics Product Types (USD/Dose)
Table Market Share of Different Biologic Therapeutics Price Level
Table Gross Margin of Different Biologic Therapeutics Applications
Table Marketing Channels Status of Biologic Therapeutics
Table Traders or Distributors of Biologic Therapeutics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biologic Therapeutics (USD/Dose) in 2015
Table United States Import, Export, and Trade of Biologic Therapeutics (Doses)
Figure United States Capacity (Doses) , Production (Doses) and Growth Rate of Biologic Therapeutics 2016-2021
Figure United States Capacity Utilization Rate of Biologic Therapeutics 2016-2021
Table United States Biologic Therapeutics Production by Type 2016-2021 (Doses)
Table United States Biologic Therapeutics Production Market Share by Type 2016-2021
Figure United States Production Market Share of Biologic Therapeutics by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Biologic Therapeutics 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Biologic Therapeutics 2016-2021
Figure United States Sales of Biologic Therapeutics by Applications 2016-2021 (Doses)
Table United States Production Market Share of Biologic Therapeutics by Applications 2016-2021
Figure United States Production Market Share of Biologic Therapeutics by Applications in 2021
Table United States Production, Import, Export and Consumption of Biologic Therapeutics 2016-2021 (Doses)
Table United States Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Revenue (M USD) and Gross Margin of Biologic Therapeutics 2016-2021
Table Major Raw Materials Suppliers of Biologic Therapeutics with Contact Information
Table Manufacturing Equipment Suppliers of Biologic Therapeutics with Contact Information
Table Major Players of Biologic Therapeutics with Contact Information
Table Key Consumers of Biologic Therapeutics with Contact Information
Table Supply Chain Relationship Analysis of Biologic Therapeutics
Table New Project SWOT Analysis of Biologic Therapeutics
Table New Project Investment Feasibility Analysis of Biologic Therapeutics
Table Part of Interviewees Record List
